E Fund Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,340
Closed -$355K 358
2024
Q1
$355K Buy
14,340
+3,244
+29% +$96.5K 0.02% 251
2023
Q4
$403K Buy
11,096
+3,037
+38% +$117K 0.03% 196
2023
Q3
$389K Buy
8,059
+1,632
+25% +$97K 0.03% 172
2023
Q2
$439K Sell
6,427
-1,622
-20% -$105K 0.03% 140
2023
Q1
$390K Buy
8,049
+806
+11% +$42.6K 0.03% 174
2022
Q4
$436K Sell
7,243
-86
-1% -$5.04K 0.04% 161
2022
Q3
$444K Sell
7,329
-2,016
-22% -$63.7K 0.04% 152
2022
Q2
$254K Buy
9,345
+2,143
+30% +$62.7K 0.02% 261
2022
Q1
$263K Buy
+7,202
New +$260K 0.01% 244

Other funds holding PRTA

E Fund Management's PRTA Position: Q2 2024 in Review

E Fund Management sold out of Prothena Corp (PRTA) in Q2 2024, closing a stake of 14,340 shares — an estimated $355K sold.

E Fund Management first reported a position in PRTA in Q1 2022 and held it in 9 quarters. The position peaked at $444K in Q3 2022. 160 funds tracked by Wall St. Rank hold PRTA as of Q2 2024.

  • E Fund Management reported no remaining Prothena Corp position as of Q2 2024 after selling out during the quarter.
  • E Fund Management sold 14,340 Prothena Corp shares in Q2 2024, an estimated $355K.
  • E Fund Management first reported a position in Prothena Corp in Q1 2022 and held it in 9 quarters.
  • E Fund Management's Prothena Corp position peaked at $444K in Q3 2022.
  • 160 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2024.

Based on E Fund Management's 13F filing for Q2 2024, filed 12 Aug 2024.